Erratum: Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies (The Lancet (2016) 387(10037) (2554–2564) (S0140673615013410) (10.1016/S0140-6736(15)01341-0));Fetal haemoglobin in sickle-cell disease: From genetic epidemiology to new therapeutic strategies

The Lancet

Volumn 387, Issue 10037, 2016, Pages 2554-2564

  Lettre, Guillaume ^a,b   Bauer, Daniel E ^c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN F; BCL11A PROTEIN, HUMAN; CARRIER PROTEIN; CHROMATIN; NUCLEAR PROTEIN;

BCL11A GENE; DNA SEQUENCE; EXPERIMENTAL THERAPY; GENE; GENETIC ASSOCIATION; GENETIC ASSOCIATION STUDY; GENETIC EPIDEMIOLOGY; GENETIC REGULATION; GENOME-WIDE ASSOCIATION STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBIN DETERMINATION; HUMAN; MOLECULAR BIOLOGY; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; ANEMIA, SICKLE CELL; ANIMAL; BIOSYNTHESIS; CHROMATIN; GENE DELETION; GENETIC TRANSCRIPTION; GENETICS; MOUSE; PHYSIOLOGY;

ANEMIA, SICKLE CELL; ANIMALS; CARRIER PROTEINS; CHROMATIN; FETAL HEMOGLOBIN; GENE DELETION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICE; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION, GENETIC;

EID: 84975091199     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)31539-2     Document Type: Erratum

References (123)

1. AC Allison Protection afforded by sickle-cell trait against subtertian malareal infection BMJ 1 1954 290 294
2. JB Herrick Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910 Yale J Biol Med 74 2001 179 184
3. J Watson The significance of the paucity of sickle cells in newborn Negro infants Am J Med Sci 215 1948 419 423
4. TH Huisman Sickle cell anemia as a syndrome: a review of diagnostic features Am J Hematol 6 1979 173 184
5. RP Perrine, MJ Brown, JB Clegg, DJ Weatherall, A May Benign sickle-cell anaemia Lancet 2 1972 1163 1167
6. BC Kar, RK Satapathy, AE Kulozik et al. Sickle cell disease in Orissa State, India Lancet 2 1986 1198 1201
7. A Alsultan, MK Alabdulaali, PJ Griffin et al. Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign Br J Haematol 164 2014 597 604
8. W Jastaniah Epidemiology of sickle cell disease in Saudi Arabia Ann Saudi Med 31 2011 289 293
9. GR Serjeant The natural history of sickle cell disease Cold Spring Harb Perspect Med 3 2013 a011783
10. OS Platt, DJ Brambilla, WF Rosse et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death N Engl J Med 330 1994 1639 1644
11. OS Platt, BD Thorington, DJ Brambilla et al. Pain in sickle cell disease. Rates and risk factors N Engl J Med 325 1991 11 16
12. O Castro, DJ Brambilla, B Thorington et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease Blood 84 1994 643 649
13. PF Milner, AP Kraus, JI Sebes et al. Sickle cell disease as a cause of osteonecrosis of the femoral head N Engl J Med 325 1991 1476 1481
14. MC Stevens, RJ Hayes, S Vaidya, GR Serjeant Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhood J Pediatr 98 1981 37 41
15. K Bailey, JS Morris, P Thomas, GR Serjeant Fetal haemoglobin and early manifestations of homozygous sickle cell disease Arch Dis Child 67 1992 517 520
16. VG Nolan, DF Wyszynski, LA Farrer, MH Steinberg Hemolysis-associated priapism in sickle cell disease Blood 106 2005 3264 3267
17. K Ohene-Frempong, SJ Weiner, LA Sleeper et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors Blood 91 1998 288 294
18. BC Wishner, KB Ward, EE Lattman, WE Love Crystal structure of sickle-cell deoxyhemoglobin at 5 A resolution J Mol Biol 98 1975 179 194
19. RL Nagel, RM Bookchin, J Johnson et al. Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S Proc Natl Acad Sci USA 76 1979 670 672
20. MA Goldberg, MA Husson, HF Bunn Participation of hemoglobins A and F in polymerization of sickle hemoglobin J Biol Chem 252 1977 3414 3421
21. HR Sunshine, J Hofrichter, WA Eaton Requirement for therapeutic inhibition of sickle haemoglobin gelation Nature 275 1978 238 240
22. C Garner, T Tatu, JE Reittie et al. Genetic influences on F cells and other hematologic variables: a twin heritability study Blood 95 2000 342 346
23. G Pilia, WM Chen, A Scuteri et al. Heritability of cardiovascular and personality traits in 6,148 Sardinians PLoS Genet 2 2006 e132
24. VG Sankaran, SH Orkin The switch from fetal to adult hemoglobin Cold Spring Harb Perspect Med 3 2013 a011643
25. D Labie, O Dunda-Belkhodja, F Rouabhi, J Pagnier, A Ragusa, RL Nagel The -158 site 5' to the G gamma gene and G gamma expression Blood 66 1985 1463 1465
26. A Bank Regulation of human fetal hemoglobin: new players, new complexities Blood 107 2006 435 443
27. L Chakalova, CS Osborne, YF Dai et al. The Corfu deltabeta thalassemia deletion disrupts gamma-globin gene silencing and reveals post-transcriptional regulation of HbF expression Blood 105 2005 2154 2160
28. VG Sankaran, J Xu, R Byron et al. A functional element necessary for fetal hemoglobin silencing N Engl J Med 365 2011 807 814
29. S Lessard, M Beaudoin, K Benkirane, G Lettre Comparison of DNA methylation profiles in human fetal and adult red blood cell progenitors Genome Med 7 2015 1
30. C Garner, J Mitchell, T Hatzis, J Reittie, M Farrall, SL Thein Haplotype mapping of a major quantitative-trait locus for fetal hemoglobin production, on chromosome 6q23 Am J Hum Genet 62 1998 1468 1474
31. C Garner, N Silver, S Best et al. Quantitative trait locus on chromosome 8q influences the switch from fetal to adult hemoglobin Blood 104 2004 2184 2186
32. GJ Dover, KD Smith, YC Chang et al. Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2 Blood 80 1992 816 824
33. G Lettre, VG Sankaran, MA Bezerra et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease Proc Natl Acad Sci USA 105 2008 11869 11874
34. SL Thein, S Menzel, X Peng et al. Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults Proc Natl Acad Sci USA 104 2007 11346 11351
35. J Close, L Game, B Clark, J Bergounioux, A Gerovassili, SL Thein Genome annotation of a 1.5 Mb region of human chromosome 6q23 encompassing a quantitative trait locus for fetal hemoglobin expression in adults BMC Genomics 5 2004 33
36. M Uda, R Galanello, S Sanna et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia Proc Natl Acad Sci USA 105 2008 1620 1625
37. R Stadhouders, S Aktuna, S Thongjuea et al. HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers J Clin Invest 124 2014 1699 1710
38. G Galarneau, CD Palmer, VG Sankaran, SH Orkin, JN Hirschhorn, G Lettre Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation Nat Genet 42 2010 1049 1051
39. VG Sankaran, TF Menne, D Scepanovic et al. MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13 Proc Natl Acad Sci USA 108 2011 1519 1524
40. S Menzel, C Garner, I Gut et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15 Nat Genet 39 2007 1197 1199
41. SN Mtatiro, T Singh, H Rooks et al. Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania PLoS One 9 2014 e111464
42. P Bhatnagar, S Purvis, E Barron-Casella et al. Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients J Hum Genet 56 2011 316 323
43. M Nuinoon, W Makarasara, T Mushiroda et al. A genome-wide association identified the common genetic variants influence disease severity in beta(0)-thalassemia/hemoglobin E Hum Genet 127 2010 303 314
44. KL Medina, H Singh Genetic networks that regulate B lymphopoiesis Curr Opin Hematol 12 2005 203 209
45. M Leid, JE Ishmael, D Avram, D Shepherd, V Fraulob, P Dollé CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis Gene Expr Patterns 4 2004 733 739
46. VG Sankaran, TF Menne, J Xu et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A Science 322 2008 1839 1842
47. VG Sankaran, J Xu, T Ragoczy et al. Developmental and species-divergent globin switching are driven by BCL11A Nature 460 2009 1093 1097
48. J Xu, C Peng, VG Sankaran et al. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing Science 334 2011 993 996
49. A Basak, M Hancarova, JC Ulirsch et al. BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations J Clin Invest 125 2015 2363 2368
50. AP Funnell, P Prontera, V Ottaviani et al. 2p15-p16.1 microdeletions encompassing and proximal to BCL11A are associated with elevated HbF in addition to neurologic impairment Blood 126 2015 89 93
51. DE Bauer, SC Kamran, S Lessard et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level Science 342 2013 253 257
52. MC Canver, EC Smith, F Sher et al. BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis Nature 527 2015 192 197
53. MT Maurano, R Humbert, E Rynes et al. Systematic localization of common disease-associated variation in regulatory DNA Science 337 2012 1190 1195
54. A Wonkam, VJ Ngo Bitoungui, AA Vorster et al. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon PLoS One 9 2014 e92506
55. P Bhatnagar, JR Keefer, JF Casella et al. Association between baseline fetal hemoglobin levels and incidence of severe vaso-occlusive pain episodes in children with sickle cell anemia Pediatr Blood Cancer 60 2013 E125 E127
56. AR Wood, T Esko, J Yang et al. Defining the role of common variation in the genomic and biological architecture of adult human height Nat Genet 46 2014 1173 1186
57. AE Locke, B Kahali, SI Berndt et al. Genetic studies of body mass index yield new insights for obesity biology Nature 518 2015 197 206
58. D Shungin, TW Winkler, DC Croteau-Chonka et al. New genetic loci link adipose and insulin biology to body fat distribution Nature 518 2015 187 196
59. PL Auer, G Lettre Rare variant association studies: considerations, challenges and opportunities Genome Med 7 2015 16
60. J Borg, P Papadopoulos, M Georgitsi et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin Nat Genet 42 2010 801 805
61. D Liu, X Zhang, L Yu et al. KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of beta-thalassemia Blood 124 2014 803 811
62. J Huang, X Zhang, D Liu et al. Compound heterozygosity for KLF1 mutations is associated with microcytic hypochromic anemia and increased fetal hemoglobin Eur J Hum Genet 23 2015 1341 1348
63. BL Sheridan, DJ Weatherall, JB Clegg et al. The patterns of fetal haemoglobin production in leukaemia Br J Haematol 32 1976 487 506
64. BP Alter, JM Rappeport, TH Huisman, WA Schroeder, DG Nathan Fetal erythropoiesis following bone marrow transplantation Blood 48 1976 843 853
65. J DeSimone, P Heller, L Hall, D Zwiers 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons Proc Natl Acad Sci USA 79 1982 4428 4431
66. OS Platt, SH Orkin, G Dover, GP Beardsley, B Miller, DG Nathan Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia J Clin Invest 74 1984 652 656
67. TR Kinney, RW Helms, EE O'Branski et al. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group Blood 94 1999 1550 1554
68. S Charache, ML Terrin, RD Moore et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia N Engl J Med 332 1995 1317 1322
69. CD Thornburg, BA Files, Z Luo et al. Impact of hydroxyurea on clinical events in the BABY HUG trial Blood 120 2012 4304 4310
70. JS Hankins, B Aygun, K Nottage et al. From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia Medicine (Baltimore) 93 2014 e215
71. MH Steinberg, WF McCarthy, O Castro et al. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17·5 year follow-up Am J Hematol 85 2010 403 408
72. E Voskaridou, D Christoulas, A Bilalis et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS) Blood 115 2010 2354 2363
73. S Charache, GJ Dover, RD Moore et al. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia Blood 79 1992 2555 2565
74. J Xu, Z Shao, K Glass et al. Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis Dev Cell 23 2012 796 811
75. LH van der Ploeg, RA Flavell DNA methylation in the human gamma delta beta-globin locus in erythroid and nonerythroid tissues Cell 19 1980 947 958
76. EC Forsberg, KM Downs, HM Christensen, H Im, PA Nuzzi, EH Bresnick Developmentally dynamic histone acetylation pattern of a tissue-specific chromatin domain Proc Natl Acad Sci USA 97 2000 14494 14509
77. R Mabaera, CA Richardson, K Johnson, M Hsu, S Fiering, CH Lowrey Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylation Blood 110 2007 1343 1352
78. TJ Ley, J DeSimone, NP Anagnou et al. 5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia N Engl J Med 307 1982 1469 1475
79. S Charache, G Dover, K Smith, CC Talbot Jr, M Moyer, S Boyer Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex Proc Natl Acad Sci USA 80 1983 4842 4846
80. J Xu, DE Bauer, MA Kerenyi et al. Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A Proc Natl Acad Sci USA 110 2013 6518 6523
81. JE Bradner, R Mak, SK Tanguturi et al. Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease Proc Natl Acad Sci USA 107 2010 12617 12622
82. MA Ruiz, A Rivers, V Ibanez et al. Hydroxymethylcytosine and demethylation of the gamma-globin gene promoter during erythroid differentiation Epigenetics 10 2015 397 407
83. M Amaya, M Desai, MN Gnanapragasam et al. Mi2β-mediated silencing of the fetal γ-globin gene in adult erythroid cells Blood 121 2013 3493 3501
84. L Shi, S Cui, JD Engel, O Tanabe Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction Nat Med 19 2013 291 294
85. S Cui, KC Lim, L Shi et al. The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice Blood 126 2015 386 396
86. A Rivers, K Vaitkus, MA Ruiz et al. RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases gamma-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model Exp Hematol 43 2015 546 553
87. CP Chaturvedi, AM Hosey, C Palii et al. Dual role for the methyltransferase G9a in the maintenance of beta-globin gene transcription in adult erythroid cells Proc Natl Acad Sci USA 106 2009 18303 18308
88. I Krivega, C Byrnes, JF de Vasconcellos et al. Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/gamma-globin looping Blood 126 2015 665 672
89. A Renneville, P Van Galen, MC Canver et al. EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression Blood 126 2015 1930 1939
90. G Rank, L Cerruti, RJ Simpson, RL Moritz, SM Jane, Q Zhao Identification of a PRMT5-dependent repressor complex linked to silencing of human fetal globin gene expression Blood 116 2010 1585 1592
91. MM Okam, EB Esrick, E Mandell, F Campigotto, DS Neuberg, BL Ebert Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea Blood 125 2015 3668 3669
92. JA Little, KP Hauser, SE Martyr et al. Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy Eur J Haematol 82 2009 315 321
93. ME Reid, A El Beshlawy, A Inati et al. A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease Am J Hematol 89 2014 709 713
94. F Esteghamat, N Gillemans, I Bilic et al. Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice Blood 121 2013 2553
95. A John, H Brylka, C Wiegreffe et al. Bcl11a is required for neuronal morphogenesis and sensory circuit formation in dorsal spinal cord development Development 139 2012 1831 1841
96. C Wiegreffe, R Simon, K Peschkes et al. Bcl11a (Ctip1) controls migration of cortical projection neurons through regulation of Sema3c Neuron 87 2015 311 325
97. P Liu, JR Keller, M Ortiz et al. Bcl11a is essential for normal lymphoid development Nature Immunol 4 2003 525 532
98. Y Yu, J Wang, W Khaled et al. Bcl11a is essential for lymphoid development and negatively regulates p53 J Exp Med 209 2012 2467 2483
99. GC Ippolito, JD Dekker, YH Wang et al. Dendritic cell fate is determined by BCL11A Proc Natl Acad Sci USA 111 2014 E998 1006
100. CM Benitez, K Qu, T Sugiyama et al. An integrated cell purification and genomics strategy reveals multiple regulators of pancreas development PLoS Genet 10 2014 e1004645
101. MC Canver, EC Smith, F Sher et al. BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis Nature 527 2015 192 197
102. DE Bauer, SH Orkin Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin Curr Opin Genet Dev 33 2015 62 70
103. MD Hoban, GJ Cost, MC Mendel et al. Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells Blood 125 2015 2597 2604
104. P Genovese, G Schiroli, G Escobar et al. Targeted genome editing in human repopulating haematopoietic stem cells Nature 510 2014 235 240
105. M Mohrin, E Bourke, D Alexander et al. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis Cell Stem Cell 7 2010 174 185
106. P Tebas, D Stein, WW Tang et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV N Engl J Med 370 2014 901 910
107. A Wilber, PW Hargrove, Y-S Kim et al. Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer Blood 117 2011 2817 2826
108. S Guda, C Brendel, R Renella et al. miRNA-embedded shRNAs for lineage-specific BCL11A knockdown and hemoglobin F induction Mol Ther 23 2015 1465 1474
109. D Zhou, K Liu, CW Sun, KM Pawlik, TM Townes KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching Nat Genet 42 2010 742 744
110. L Arnaud, C Saison, V Helias et al. A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia Am J Hum Genet 87 2010 721 727
111. V Viprakasit, S Ekwattanakit, S Riolueang et al. Mutations in Kruppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression Blood 123 2014 1586 1595
112. GW Magor, MR Tallack, KR Gillinder et al. KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome Blood 125 2015 2405 2417
113. W Deng, J Lee, H Wang et al. Controlling long-range genomic interactions at a native locus by targeted tethering of a looping factor Cell 149 2012 1233 1244
114. W Deng, JW Rupon, I Krivega et al. Reactivation of developmentally silenced globin genes by forced chromatin looping Cell 158 2014 849 860
115. J Xu, VG Sankaran, M Ni et al. Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6 Genes Dev 24 2010 783 798
116. YT Lee, JF de Vasconcellos, J Yuan et al. LIN28B-mediated expression of fetal hemoglobin and production of fetal-like erythrocytes from adult human erythroblasts ex vivo Blood 122 2013 1034 1041
117. H Hennemann, S Wirths, C Carl Cell-based peptide screening to access the undruggable target space Eur J Med Chem 94 2015 489 496
118. GE Winter, DL Buckley, J Paulk et al. Drug Development. Phthalimide conjugation as a strategy for in vivo target protein degradation Science 348 2015 1376 1381
119. J Kronke, EC Fink, PW Hollenbach et al. Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS Nature 523 2015 183 188
120. J Kronke, ND Udeshi, A Narla et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells Science 343 2014 301 305
121. SE Meiler, M Wade, F Kutlar et al. Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice Blood 118 2011 1109 1112
122. Moutouh-De Parseval La, D Verhelle, E Glezer et al. Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells J Clin Invest 118 2008 248 258
123. SK Obaro Hydroxyurea for sickle-cell anaemia in Africa: mind the gap Lancet Glob Health 3 2015 e124 e125